Table 3 Prognosis of up-regulated HSP90 in different subtypes of breast cancer.
Subtype | Event phenotype | Kaplan-Meier survival analysis | COXPH survival analysis | |||||
|---|---|---|---|---|---|---|---|---|
| Â | Â | P-value | HR (95%CI) | n | P-value | Co-efficiency | P-adjusted | n |
All samples | Death | 0.0034 | 1.57 (1.16-2.12) | 1072 | 0.0007 | 0.5714 | 0.0062 | 421 |
HER2+ | Death | 0.3118 | 1.40 (0.73-2.71) | 194 | 0.2564 | 0.7433 | 0.1405 | 63 |
| Â | Recurrence | 0.475 | 0.87 (0.58-1.29) | 204 | 0.9528 | -0.2160 | 0.6705 | 72 |
| Â | Distant metastasis | 0.2292 | 0.77 (0.50-1.18) | 347 | 0.5383 | -0.6461 | 0.2330 | 90 |
HER2-/ER+ | Death | 0.0148 | 1.71 (1.11-2.63) | 506 | 0.0003 | 0.8373 | 0.0042 | 228 |
| Â | Recurrence | 0.0183 | 1.31 (1.05-1.65) | 832 | 0.1790 | 0.2077 | 0.3054 | 361 |
| Â | Distant metastasis | 0.0002 | 1.65 (1.27-2.15) | 1223 | 0.0098 | 0.4050 | 0.0705 | 415 |
TNBC | Death | 0.0604 | 1.76 (0.98-3.19) | 282 | 0.5693 | 0.2586 | 0.5869 | 105 |
| Â | Recurrence | 0.0002 | 2.29 (1.49-3.52) | 285 | 0.0008 | 0.9924 | 0.0101 | 122 |
| Â | Distant metastasis | 0.0195 | 1.60 (1.08-2.37) | 516 | 0.6722 | -0.0323 | 0.9390 | 158 |